The GLP is committed to full transparency. Download and review our 2019 Annual Report

Bayer nears end game in merger talks with Monsanto

, | | September 6, 2016
Bayer MonsantoMerger
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

German pharmaceutical and crops manufacturer Bayer AG (BAYGn.DE) said on [September 5, 2016] that its negotiations with Monsanto Co (MON.N) had advanced, and it was now willing to offer more than $65 billion to acquire the world’s largest seed company.

Bayer in a statement said that it was prepared to offer $127.50 per share in connection with a negotiated deal, up from its previous offer of $125 per share.

ChemChina agreed earlier this year to buy Switzerland’s Syngenta (SYNN.S) for $43 billion, after the latter rejected takeover approaches from Monsanto. Dow Chemical Co (DOW.N) and DuPont (DD.N) are forging a $130 billion merger, which is to be followed by a break-up into three businesses.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. Read full, original post: Bayer sweetens Monsanto bid as talks enter final stretch

News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend